Related Experiment Video
Updated: Oct 3, 2026

Noninvasive Determination of Vortex Formation Time Using Transesophageal Echocardiography During Cardiac Surgery
Published on: November 28, 2018
Effect of low-flow, very low-gradient aortic stenosis on survival and objective functional recovery after TAVI
José M de la Torre-Hernández1, Gabriela Veiga1, Rigoberto Hernández1
1Departamento de Cardiología, Hospital Universitario Marqués de Valdecilla, Instituto de Investigación Valdecilla (IDIVAL), Santander, Cantabria, Spain.
Introduction And Objectives:
It is unclear how the magnitude of reductions in baseline mean aortic gradient and flow affects clinical outcomes after TAVI. This study aimed to assess the prognostic impact of low-flow very low-gradient (LF-VLG) aortic stenosis on survival and objective functional recovery after TAVI.
Methods:
Data from the Spanish TAVI Registry were analyzed. Three groups were included: high-gradient (≥ 40 mmHg), low-flow low-gradient (LF-LG) (20-39 mmHg) and LF-VLG (≤ 20 mmHg). A prospective single-center substudy was conducted to evaluate objective functional recovery after TAVI.
Results:
A total of 17 836 patients were included. Two-year survival was 82% in the high-gradient group (n = 12 800), 79% in the LF-LG group (n = 4126), and 73.2% in the LF-VLG group (n = 495) (P < .0001). In patients with LF-VLG, coronary artery disease and atrial fibrillation, but not ejection fraction, independently predicted mortality. In a cohort of 465 patients, objective improvement was observed in 88% of patients in the high-gradient group, 70% in the LF-LG group, and 57% in the LF-VLG group (P < .0001).
Conclusions:
Patients with LF-VLG aortic stenosis show reduced but acceptable 2-year survival regardless of ejection fraction and limited functional recovery at 6 months after TAVI. Coronary artery disease and atrial fibrillation were independent predictors of mortality.
Related Concept Videos
Aortic Regurgitation IV: Nursing Management
Aortic Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management